Maria Nucera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maria Nucera has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Florian S. Schoenhoff
Department of Cardiac Surgery, Inselspital, Bern University Hospital, University of Bern , Bern 3010
5 shared publications - Matthias Siepe
Department of Cardiac Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
5 shared publications Matthias Siepe
Department of Cardiac Surgery, Centre for Congenital Heart Disease, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
4 shared publicationsMurat Yildiz
Inselspital, University Hospital Bern
4 shared publications- Murat Yildiz
Department of Cardiac Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
3 shared publications Selim Mosbahi
Department of Cardiac Surgery, Inselspital, Bern University Hospital, University of Bern , Bern
3 shared publications
Latest Publications
- Open Access
- 16 October 2026
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
Functional outcome after recurrent laryngeal nerve injury following thoracic aortic surgery
- 16 October 2026
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
Open AccessFunctional outcome after recurrent laryngeal nerve injury following thoracic aortic surgery
- Open Access
Frozen elephant trunk repair in heritable thoracic aortic disease: Impact of genetic aortopathy on long-term outcomes - A multicenter analysis
Aims This multicenter study aims to compare outcomes of total aortic arch replacement (TAR) using the frozen elephant trunk (FET) technique in patients with and without heritable thoracic aortic disease (HTAD) and to assess whether HTAD influences postprocedural adverse aortic events (AAEs). Methods From 06/2007 to 05/2024, aortic databases from 13 European centers were screened for HTAD patients undergoing TAR with FET. All consecutive dissection and aneurysm non-HTAD patients from the four core centers served as comparator. The primary outcome was AAE, a composite of diameter progression, distal stent graft induced new entry (dSINE), malperfusion, rupture and pseudoaneurysm at 5 years after FET implantation. Results Of 2739 FET patients, 196 (7.2%) were diagnosed with HTAD. The control group consisted of 867 non-HTAD FET patients. Marfan syndrome was the most common condition (72%), followed by Loeys-Dietz syndrome (11%), vascular Ehlers-Danlos syndrome (5.6%) and Turner syndrome (2.0%). Seventeen (8.8%) patients were diagnosed with ns-HTAD. At 5 years 46 (24%) AAEs occurred in the HTAD group, 169 (20%) in the non-HTAD group (p=0.2). Diameter progression was the most common event (10% vs. 12%; p=0.6), followed by dSINE (5.8% vs. 4.5%; p=0.5), malperfusion (4.2% vs. 3.3%; p=0.5), rupture (2.1% vs. 0.7%; p=0.09) and pseudoaneurysm (0.5% vs. 0.2%; p=0.5). Conclusions The FET technique appears safe and effective for acute and chronic aortic disease in HTAD patients, with outcomes comparable to non-HTAD cases and no increase in graft-related complications, challenging traditional concerns about stent graft use in genetically mediated aortic disease.
Open AccessFrozen elephant trunk repair in heritable thoracic aortic disease: Impact of genetic aortopathy on long-term outcomes - A multicenter analysis
Aims This multicenter study aims to compare outcomes of total aortic arch replacement (TAR) using the frozen elephant trunk (FET) technique in patients with and without heritable thoracic aortic disease (HTAD) and to assess whether HTAD influences postprocedural adverse aortic events (AAEs). Methods From 06/2007 to 05/2024, aortic databases from 13 European centers were screened for HTAD patients undergoing TAR with FET. All consecutive dissection and aneurysm non-HTAD patients from the four core centers served as comparator. The primary outcome was AAE, a composite of diameter progression, distal stent graft induced new entry (dSINE), malperfusion, rupture and pseudoaneurysm at 5 years after FET implantation. Results Of 2739 FET patients, 196 (7.2%) were diagnosed with HTAD. The control group consisted of 867 non-HTAD FET patients. Marfan syndrome was the most common condition (72%), followed by Loeys-Dietz syndrome (11%), vascular Ehlers-Danlos syndrome (5.6%) and Turner syndrome (2.0%). Seventeen (8.8%) patients were diagnosed with ns-HTAD. At 5 years 46 (24%) AAEs occurred in the HTAD group, 169 (20%) in the non-HTAD group (p=0.2). Diameter progression was the most common event (10% vs. 12%; p=0.6), followed by dSINE (5.8% vs. 4.5%; p=0.5), malperfusion (4.2% vs. 3.3%; p=0.5), rupture (2.1% vs. 0.7%; p=0.09) and pseudoaneurysm (0.5% vs. 0.2%; p=0.5). Conclusions The FET technique appears safe and effective for acute and chronic aortic disease in HTAD patients, with outcomes comparable to non-HTAD cases and no increase in graft-related complications, challenging traditional concerns about stent graft use in genetically mediated aortic disease.
- Open Access
- 9 December 2025
- Published by Springer Nature in Pediatric Nephrology
- Vol. 41 (5) , 1347-1350
Mini-sternotomy for direct right atrial dialysis catheter placement in a child with central venous occlusion
We report the case of a pediatric patient with kidney failure and bilateral central venous occlusion, in whom conventional dialysis access was no longer feasible. Following multidisciplinary evaluation, a dialysis catheter was surgically inserted directly into the right atrium via a lower mini-sternotomy. A custom-made bovine pericardial conduit was used to facilitate extrathoracic tunnelling and protect the catheter. The procedure was technically successful, and the catheter remained functional postoperatively. This case highlights a viable salvage option for dialysis access in children with exhausted vascular access sites.
- 9 December 2025
- Published by Springer Nature in Pediatric Nephrology
- Vol. 41 (5) , 1347-1350
Open AccessMini-sternotomy for direct right atrial dialysis catheter placement in a child with central venous occlusion
We report the case of a pediatric patient with kidney failure and bilateral central venous occlusion, in whom conventional dialysis access was no longer feasible. Following multidisciplinary evaluation, a dialysis catheter was surgically inserted directly into the right atrium via a lower mini-sternotomy. A custom-made bovine pericardial conduit was used to facilitate extrathoracic tunnelling and protect the catheter. The procedure was technically successful, and the catheter remained functional postoperatively. This case highlights a viable salvage option for dialysis access in children with exhausted vascular access sites.
- Open Access
- 6 October 2025
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 40 (10)
The Heart That Took the Scenic Route: Europe’s Record-Breaking 9-Hours OCS Journey
We report Europe’s longest documented heart perfusion using the Transmedics Organ Care System (OCS) during a heart transplantation. A 55-year-old patient with end-stage heart failure received a donor heart after 536 minutes (8 hours 55 minutes) of OCS perfusion and a total out-of-body time of 676 minutes (11 hours 16 minutes). Due to adverse weather, air transport was not possible, necessitating an extended ground-based journey. Despite initial vasospasm, perfusion parameters remained stable. The heart demonstrated immediate post-transplant function without the need of mechanical support. This case demonstrates the potential of the OCS to extend preservation times beyond conventional limits, increasing access to viable donor organs and optimizing transplantation outcomes.
- 6 October 2025
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 40 (10)
Open AccessThe Heart That Took the Scenic Route: Europe’s Record-Breaking 9-Hours OCS Journey
We report Europe’s longest documented heart perfusion using the Transmedics Organ Care System (OCS) during a heart transplantation. A 55-year-old patient with end-stage heart failure received a donor heart after 536 minutes (8 hours 55 minutes) of OCS perfusion and a total out-of-body time of 676 minutes (11 hours 16 minutes). Due to adverse weather, air transport was not possible, necessitating an extended ground-based journey. Despite initial vasospasm, perfusion parameters remained stable. The heart demonstrated immediate post-transplant function without the need of mechanical support. This case demonstrates the potential of the OCS to extend preservation times beyond conventional limits, increasing access to viable donor organs and optimizing transplantation outcomes.
- Open Access
- 21 August 2025
- Published by Springer Nature in Research Square
Mini-sternotomy for direct right atrial dialysis catheter placement in a child with central venous occlusion
We report the case of a pediatric patient with end-stage renal disease and bilateral central venous occlusion, in whom conventional dialysis access was no longer feasible. Following multidisciplinary evaluation, a dialysis catheter was surgically inserted directly into the right atrium via a lower mini-sternotomy. A custom-made bovine pericardial conduit was used to facilitate extrathoracic tunnelling and protect the catheter. The procedure was technically successful, and the catheter remained functional postoperatively. This case highlights a viable salvage option for dialysis access in children with exhausted vascular access sites.
- 21 August 2025
- Published by Springer Nature in Research Square
Open AccessMini-sternotomy for direct right atrial dialysis catheter placement in a child with central venous occlusion
We report the case of a pediatric patient with end-stage renal disease and bilateral central venous occlusion, in whom conventional dialysis access was no longer feasible. Following multidisciplinary evaluation, a dialysis catheter was surgically inserted directly into the right atrium via a lower mini-sternotomy. A custom-made bovine pericardial conduit was used to facilitate extrathoracic tunnelling and protect the catheter. The procedure was technically successful, and the catheter remained functional postoperatively. This case highlights a viable salvage option for dialysis access in children with exhausted vascular access sites.
- Open Access
- 23 June 2025
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 40 (7)
Management of the aortic arch in patients with syndromic heritable thoracic aortic disease
OBJECTIVES: The aim of this study was to examine the evolution of the aortic arch over time in patients with HTAD. METHODS: We screened all patients with Marfan syndrome (MFS) or Loeys–Dietz syndrome (LDS) who were seen at our HTAD clinic since 1995. Patients who had undergone aortic surgery were included in the present study. Patients were analysed based on (1) extent of aortic arch replacement, (2) history of aortic dissection and (3) outcome after secondary total aortic arch replacement (TAR). RESULTS: A cohort of 260 patients was identified of whom 165 patients with MFS (n = 138) and LDS (n = 27) had already undergone aortic surgery and were included in this study. LDS: initial presentation was acute aortic dissection (AAD) in five (19%) patients, while 22 (81%) patients presented with aneurysmal disease. Only two patients required secondary TAR during follow-up. MFS: initial presentation was AAD in 41 (30%) patients, while 97 (70%) presented with aneurysmal disease. Only 3% (n = 3) of the MFS patients without primary aortic arch replacement required a secondary TAR. There was significantly more secondary TAR in MFS patients with history of aortic dissection compared to those without (P = 0.019). However, there was no significant differences in rate of downstream aortic events in MFS patients with secondary TAR compared to those without (P = 0.089). There was no significant difference in mortality in MFS patients with secondary TAR compared to those without (P = 0.366). CONCLUSIONS: Concomitant prophylactic TAR in MFS patients undergoing elective root repair is not justified. One out of four MFS patients with history of AAD will have to undergo secondary TAR during follow-up. MFS patients undergoing secondary TAR do not have worse survival compared to those without. Current data do not provide enough evidence for strong recommendations regarding the need for prophylactic aortic arch replacement in LDS patients.
- 23 June 2025
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 40 (7)
Open AccessManagement of the aortic arch in patients with syndromic heritable thoracic aortic disease
OBJECTIVES: The aim of this study was to examine the evolution of the aortic arch over time in patients with HTAD. METHODS: We screened all patients with Marfan syndrome (MFS) or Loeys–Dietz syndrome (LDS) who were seen at our HTAD clinic since 1995. Patients who had undergone aortic surgery were included in the present study. Patients were analysed based on (1) extent of aortic arch replacement, (2) history of aortic dissection and (3) outcome after secondary total aortic arch replacement (TAR). RESULTS: A cohort of 260 patients was identified of whom 165 patients with MFS (n = 138) and LDS (n = 27) had already undergone aortic surgery and were included in this study. LDS: initial presentation was acute aortic dissection (AAD) in five (19%) patients, while 22 (81%) patients presented with aneurysmal disease. Only two patients required secondary TAR during follow-up. MFS: initial presentation was AAD in 41 (30%) patients, while 97 (70%) presented with aneurysmal disease. Only 3% (n = 3) of the MFS patients without primary aortic arch replacement required a secondary TAR. There was significantly more secondary TAR in MFS patients with history of aortic dissection compared to those without (P = 0.019). However, there was no significant differences in rate of downstream aortic events in MFS patients with secondary TAR compared to those without (P = 0.089). There was no significant difference in mortality in MFS patients with secondary TAR compared to those without (P = 0.366). CONCLUSIONS: Concomitant prophylactic TAR in MFS patients undergoing elective root repair is not justified. One out of four MFS patients with history of AAD will have to undergo secondary TAR during follow-up. MFS patients undergoing secondary TAR do not have worse survival compared to those without. Current data do not provide enough evidence for strong recommendations regarding the need for prophylactic aortic arch replacement in LDS patients.
- Open Access
- 18 February 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (4) , e036495
One‐Year Functional Outcome of Patients After Surgery for Acute Stanford Type A Aortic Dissection
Background: Our aim was to report the functional outcome of Stanford type A aortic dissection (TAAD) after 1 year as well as morbidity and mortality. Methods and Results: This is a retrospective analysis including 642 patients with TAAD from January 2005 to December 2021. Mean age at TAAD was 62 years (95% CI, 61–63), and 30% of the population were women. One year after surgery for TAAD, 75% of patients were living at home with New York Heart Association functional class I. No patients were observed with New York Heart Association functional class IV. Less than 2% resided in an assisted‐living facility. Eighty‐five percent of nonretired patients had returned to work. Two hundred twelve (33%) patients were retired after 1 year at a mean age of 73 years (95% CI, 72–74). Stroke (defined as any kind of neurological symptoms) occurred in 148 (23%) patients and was the cause of death in 33 patients. Of the remaining patients with stroke, 115 (30%) had no residual limitations 1 year after TAAD. The cross‐clamp time was significantly higher in patients with stroke (98 minutes [95% CI, 94.0–101.1] in patients without stroke versus 106 minutes [95% CI, 98.5–114.1] in patients with stroke; P =0.026). Sixty‐nine percent of patients with stroke lived at home, 28% lived at home with support, and 3% lived in an assisted‐living facility. One year after stroke, 77% of the patients achieved a modified Rankin Scale score ≤2, whereas no patient had a modified Rankin Scale score of 5. There was no significant correlation between sex and recovery rate ( P =0.48). However, experiencing a stroke significantly increased the likelihood of residing in an assisted‐living facility or receiving support at home 1 year after TAAD (odds ratio, 9.46 [95% CI, 5.06–17.70]; P P =0.101). Conclusions: One year after surgery for Stanford acute type A aortic dissection, almost 3 out of 4 patients lived unassisted at home. Stroke survivors have a favorable outcome, with the majority having mild or no residual neurological deficits at 1 year.
- 18 February 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (4) , e036495
Open AccessOne‐Year Functional Outcome of Patients After Surgery for Acute Stanford Type A Aortic Dissection
Background: Our aim was to report the functional outcome of Stanford type A aortic dissection (TAAD) after 1 year as well as morbidity and mortality. Methods and Results: This is a retrospective analysis including 642 patients with TAAD from January 2005 to December 2021. Mean age at TAAD was 62 years (95% CI, 61–63), and 30% of the population were women. One year after surgery for TAAD, 75% of patients were living at home with New York Heart Association functional class I. No patients were observed with New York Heart Association functional class IV. Less than 2% resided in an assisted‐living facility. Eighty‐five percent of nonretired patients had returned to work. Two hundred twelve (33%) patients were retired after 1 year at a mean age of 73 years (95% CI, 72–74). Stroke (defined as any kind of neurological symptoms) occurred in 148 (23%) patients and was the cause of death in 33 patients. Of the remaining patients with stroke, 115 (30%) had no residual limitations 1 year after TAAD. The cross‐clamp time was significantly higher in patients with stroke (98 minutes [95% CI, 94.0–101.1] in patients without stroke versus 106 minutes [95% CI, 98.5–114.1] in patients with stroke; P =0.026). Sixty‐nine percent of patients with stroke lived at home, 28% lived at home with support, and 3% lived in an assisted‐living facility. One year after stroke, 77% of the patients achieved a modified Rankin Scale score ≤2, whereas no patient had a modified Rankin Scale score of 5. There was no significant correlation between sex and recovery rate ( P =0.48). However, experiencing a stroke significantly increased the likelihood of residing in an assisted‐living facility or receiving support at home 1 year after TAAD (odds ratio, 9.46 [95% CI, 5.06–17.70]; P P =0.101). Conclusions: One year after surgery for Stanford acute type A aortic dissection, almost 3 out of 4 patients lived unassisted at home. Stroke survivors have a favorable outcome, with the majority having mild or no residual neurological deficits at 1 year.
- 20 January 2025
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 67 (2)
Revisiting ascending aortic resection in the elective valve-sparing root replacement: assessing the benefits and necessity of hemiarch replacement at three centres
OBJECTIVE: The aim of this study was to determine the indication and optimal timing for performing a hemiarch procedure in patients undergoing valve-sparing root replacement (VSRR). METHODS: We conducted a retrospective study on 986 patients undergoing VSRR at three tertiary care centres. Inclusion criteria were all patients undergoing elective VSRR. Exclusion criteria were age 0.999). Similarly, no difference was found for aortic reinterventions (P = 0.13) or survival (P = 0.5). This was also true for patients with heritable thoracic aortic disease. However, in patients with a bicuspid aortic valve, the intervention rate was significantly higher in the hemiarch group (10.8% vs 0%, P = 0.016). There was no significant difference in the 30-day incidence of cerebrovascular accidents between the groups (5% vs 2.7% in the hemiarch group, P = 0.117). Only the distal ascending diameter showed a tendency with better outcome over 45 mm for the hemiarch procedure; otherwise, we found no reliable cut-off values based on ascending length, diameter-to-height index or ascending length-to-height index. CONCLUSIONS: Our findings conclusively demonstrate that concomitant hemiarch replacement does not increase the perioperative risk in young patients undergoing VSRR. However, concomitant replacement does not seem to protect from aortic reinterventions during medium-term follow-up.
- 20 January 2025
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 67 (2)
Revisiting ascending aortic resection in the elective valve-sparing root replacement: assessing the benefits and necessity of hemiarch replacement at three centres
OBJECTIVE: The aim of this study was to determine the indication and optimal timing for performing a hemiarch procedure in patients undergoing valve-sparing root replacement (VSRR). METHODS: We conducted a retrospective study on 986 patients undergoing VSRR at three tertiary care centres. Inclusion criteria were all patients undergoing elective VSRR. Exclusion criteria were age 0.999). Similarly, no difference was found for aortic reinterventions (P = 0.13) or survival (P = 0.5). This was also true for patients with heritable thoracic aortic disease. However, in patients with a bicuspid aortic valve, the intervention rate was significantly higher in the hemiarch group (10.8% vs 0%, P = 0.016). There was no significant difference in the 30-day incidence of cerebrovascular accidents between the groups (5% vs 2.7% in the hemiarch group, P = 0.117). Only the distal ascending diameter showed a tendency with better outcome over 45 mm for the hemiarch procedure; otherwise, we found no reliable cut-off values based on ascending length, diameter-to-height index or ascending length-to-height index. CONCLUSIONS: Our findings conclusively demonstrate that concomitant hemiarch replacement does not increase the perioperative risk in young patients undergoing VSRR. However, concomitant replacement does not seem to protect from aortic reinterventions during medium-term follow-up.
- 1 March 2024
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 65 (3)
Endovascular aortic repair in patients with Marfan and Loeys–Dietz syndrome is safe and durable when employed by a multi-disciplinary aortic team
The aim of this study was to report on mid-term outcomes after endovascular aortic repair in patients with Marfan (MFS) or Loeys-Dietz (LDS) syndrome. We analyzed data from two European centers of patients with MFS and LDS undergoing endovascular aortic repair. Patients were analyzed based on (1) timing of the procedure (planned vs emergency procedure) and (2) the nature of the landing zone (safe vs non-safe). The primary end-point was freedom from reintervention. Secondary end-points were freedom from stroke, bleeding and death. A population of 419 patients with MFS (n = 352) or LDS (n = 67) was analyzed for the purpose of this study. Thirty-nine patients (9%) underwent endovascular aortic repair. Indications for TEVAR or EVAR were aortic dissection in 13 (33%) patients, aortic aneurysm in 22 (57%) patients and others (intercostal patch aneurysm, penetrating atherosclerotic ulcer, pseudoaneurysm, kinking of FET) in 4 (10%) patients. Thoracic endovascular repair was performed in 34 patients, abdominal endovascular aortic repair was performed in 5 patients. Mean age at 1st TEVAR/EVAR was 48.5 ± 15.4y. Mean follow-up after 1st TEVAR/EVAR was 5.9 ± 4.4 y. There was no statistically significant difference in the rate of re-interventions between patients with non-safe landing zone and the patients with safe proximal landing zone (P = 0.609). Furthermore, there was no increased probability for reintervention after planned endovascular intervention compared to emergency procedures (P = 0.916). Mean-time to reintervention, either open surgical or endovascular, after planned endovascular intervention was in median 3.9 y [95% CI 2.0–5.9y] and 2.0 y [95% CI -1.1–5.1y] (P = 0.23) after emergency procedures. Endovascular aortic repair in patients with MFS and LDS and a safe landing zone is feasible and safe. Endovascular treatment is a viable option when employed by a multi-disciplinary aortic team even if the landing zone is in native tissue.
- 1 March 2024
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 65 (3)
Endovascular aortic repair in patients with Marfan and Loeys–Dietz syndrome is safe and durable when employed by a multi-disciplinary aortic team
The aim of this study was to report on mid-term outcomes after endovascular aortic repair in patients with Marfan (MFS) or Loeys-Dietz (LDS) syndrome. We analyzed data from two European centers of patients with MFS and LDS undergoing endovascular aortic repair. Patients were analyzed based on (1) timing of the procedure (planned vs emergency procedure) and (2) the nature of the landing zone (safe vs non-safe). The primary end-point was freedom from reintervention. Secondary end-points were freedom from stroke, bleeding and death. A population of 419 patients with MFS (n = 352) or LDS (n = 67) was analyzed for the purpose of this study. Thirty-nine patients (9%) underwent endovascular aortic repair. Indications for TEVAR or EVAR were aortic dissection in 13 (33%) patients, aortic aneurysm in 22 (57%) patients and others (intercostal patch aneurysm, penetrating atherosclerotic ulcer, pseudoaneurysm, kinking of FET) in 4 (10%) patients. Thoracic endovascular repair was performed in 34 patients, abdominal endovascular aortic repair was performed in 5 patients. Mean age at 1st TEVAR/EVAR was 48.5 ± 15.4y. Mean follow-up after 1st TEVAR/EVAR was 5.9 ± 4.4 y. There was no statistically significant difference in the rate of re-interventions between patients with non-safe landing zone and the patients with safe proximal landing zone (P = 0.609). Furthermore, there was no increased probability for reintervention after planned endovascular intervention compared to emergency procedures (P = 0.916). Mean-time to reintervention, either open surgical or endovascular, after planned endovascular intervention was in median 3.9 y [95% CI 2.0–5.9y] and 2.0 y [95% CI -1.1–5.1y] (P = 0.23) after emergency procedures. Endovascular aortic repair in patients with MFS and LDS and a safe landing zone is feasible and safe. Endovascular treatment is a viable option when employed by a multi-disciplinary aortic team even if the landing zone is in native tissue.
- 16 June 2023
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 72 (08) , 614-623
Transapical Transcatheter Mitral Valve Implantation with the Tendyne Valve: The Swiss Experience
Background The aim of this study was to report outcomes of all patients undergoing transcatheter mitral valve implantation with the Tendyne Mitral Valve System (Tendyne) in Switzerland. Methods We retrospectively analyzed preoperative echocardiographic and computed tomography (CT) data, procedural findings, and 30-day and 1-year follow-up echocardiographic and clinical data of patients who underwent transcatheter mitral valve implantation with Tendyne in Switzerland. Results A total of 24 patients (age, 74.8 ± 7.8 years; 67% male) underwent transapical transcatheter mitral valve implantation with Tendyne between June 2020 and October 2022. Technical success rate was 96%. In five patients, concomitant interventions in the form of transcatheter aortic valve implantation (one patient), minimally invasive direct coronary artery bypass (one patient), and transcatheter edge-to-edge repair (three patients) were performed prior to or after the index procedure. There was one device embolization, and two patients required valve retrieval. In-hospital outcomes included one stroke and three major bleeding events. None of the patients died within 30 days. Two patients were rehospitalized for decompensated heart failure. At 1-year follow-up, there were three noncardiovascular-related deaths. Conclusion Transcatheter mitral valve implantation with Tendyne is feasible to treat polymorbid patients suffering from complex mitral valve disease as well as patients with previous mitral interventions. Perioperative risk was acceptable and procedural success high. The study was undertaken in equal parts in Bern and Basel. David Reineke and Oliver Reuthebuch have selected the patients, done the procedures, and are therefore in equal parts at the origin of this work. They have initiated the publication of the data and designed its outlines. They have treated the patients, collected their consent and done the in-house follow-up, designed the paper, and edited the article with focus on the patients at their centers. The same applies for the first authors, who had corresponding roles at their centers, doing follow-up for their patients, getting the ethic committees approval for their respective patients, and writing the document. The same applied for the review. The only thing that was done exclusively in one center is the filming of the procedure. Raw data were generated at University Hospital Bern and at University Hospital Basel. All relevant data are within the manuscript. * These authors contributed equally to this manuscript and are joint first authors. ** These authors contributed equally to this manuscript and are joint last authors. Received: 17 November 2022 Accepted: 13 April 2023 Article published online: 16 June 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 16 June 2023
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 72 (08) , 614-623
Transapical Transcatheter Mitral Valve Implantation with the Tendyne Valve: The Swiss Experience
Background The aim of this study was to report outcomes of all patients undergoing transcatheter mitral valve implantation with the Tendyne Mitral Valve System (Tendyne) in Switzerland. Methods We retrospectively analyzed preoperative echocardiographic and computed tomography (CT) data, procedural findings, and 30-day and 1-year follow-up echocardiographic and clinical data of patients who underwent transcatheter mitral valve implantation with Tendyne in Switzerland. Results A total of 24 patients (age, 74.8 ± 7.8 years; 67% male) underwent transapical transcatheter mitral valve implantation with Tendyne between June 2020 and October 2022. Technical success rate was 96%. In five patients, concomitant interventions in the form of transcatheter aortic valve implantation (one patient), minimally invasive direct coronary artery bypass (one patient), and transcatheter edge-to-edge repair (three patients) were performed prior to or after the index procedure. There was one device embolization, and two patients required valve retrieval. In-hospital outcomes included one stroke and three major bleeding events. None of the patients died within 30 days. Two patients were rehospitalized for decompensated heart failure. At 1-year follow-up, there were three noncardiovascular-related deaths. Conclusion Transcatheter mitral valve implantation with Tendyne is feasible to treat polymorbid patients suffering from complex mitral valve disease as well as patients with previous mitral interventions. Perioperative risk was acceptable and procedural success high. The study was undertaken in equal parts in Bern and Basel. David Reineke and Oliver Reuthebuch have selected the patients, done the procedures, and are therefore in equal parts at the origin of this work. They have initiated the publication of the data and designed its outlines. They have treated the patients, collected their consent and done the in-house follow-up, designed the paper, and edited the article with focus on the patients at their centers. The same applies for the first authors, who had corresponding roles at their centers, doing follow-up for their patients, getting the ethic committees approval for their respective patients, and writing the document. The same applied for the review. The only thing that was done exclusively in one center is the filming of the procedure. Raw data were generated at University Hospital Bern and at University Hospital Basel. All relevant data are within the manuscript. * These authors contributed equally to this manuscript and are joint first authors. ** These authors contributed equally to this manuscript and are joint last authors. Received: 17 November 2022 Accepted: 13 April 2023 Article published online: 16 June 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany